Home / Catalog / Drugs & devices
Drugs & devicesSource-backed product
FDA Orange Book
The FDA's record of approved drugs with their patents, exclusivity periods, and generic-equivalence ratings. Used to work out when a brand drug's protections lapse and a generic can launch.
What Vlada adds: Preserves the publisher data, normalizes schema eras and identifiers, and connects the product to compatible healthcare entities with measured join coverage.
- rows
- 1.2M
- rows
- datasets
- 3
- datasets
- cadence
- monthly
- cadence
- coverage
- 2021-2026
- coverage
Publishers: U.S. Food and Drug Administration
What's inside
FDA Orange Book (patents + exclusivity)
FDA approved-drug products with therapeutic-equivalence, patent, and exclusivity metadata.
grain: One row per (application_number, product_id, observed_month).
820.8K rows
FDA Orange Book — patents
FDA Orange Book patent listings — patents protecting approved drugs by application/product, with patent number, use code, expiry, and substance/product flags.
grain: One row per (application, product, patent) — Orange Book patent listing.
340.8K rows
FDA Orange Book — exclusivity
FDA Orange Book exclusivity periods by application/product — exclusivity code and expiry.
grain: One row per (application, product, exclusivity_code) — market exclusivity.
38.7K rows